Carcinoma, Basal Cell: Clinical Trials

205 completed, 60 unknown, 42 recruiting, 23 terminated. 102 Phase 2, 94 Not applicable, 53 Phase 1, 26 Phase 3, 11 Early Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	102	Completed 53, Recruiting 13, Terminated 10, Unknown 10, Active not recruiting 8, Not yet recruiting 3, Withdrawn 3, Suspended 2
Not applicable	94	Completed 50, Unknown 20, Recruiting 10, Active not recruiting 4, Withdrawn 4, Terminated 3, Not yet recruiting 2, Suspended 1
Phase 1	53	Completed 31, Recruiting 7, Terminated 5, Unknown 5, Active not recruiting 4, Suspended 1
Phase 3	26	Completed 16, Unknown 3, Recruiting 2, Terminated 2, Active not recruiting 1, Enrolling by invitation 1, Withdrawn 1
Early Phase 1	11	Completed 6, Recruiting 2, Terminated 1, Unknown 1, Withdrawn 1
Phase 4	10	Completed 7, Unknown 2, Not yet recruiting 1

Follow Carcinoma, Basal Cell: new trials by email Literature Review of Carcinoma, Basal Cell trials Research Report on Carcinoma, Basal Cell

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8	Phase 2	Not yet recruiting	Fred Hutchinson Cancer Center	50	2026-12-01	2026-09-17
A Study Comparing Cemiplimab-based Treatments for Adult Participants With Locally Advanced Basal Cell Skin Cancer (laBCC) Cemiplimab, Vidutolimod, Fianlimab - Locally Advanced Basal Cell Carcinoma	Phase 2	Not yet recruiting	Regeneron Pharmaceuticals	135	2026-10-15	2026-09-09
Basal Cell Carcinoma Chemoprevention Trial 5% Imiquimod cream, Placebo Vehicle Control Cream - Basal Cell Carcinoma	Phase 3	Recruiting	VA Office of Research and Development	1630	2026-10-06	2026-10-19
Impact of Dysport on PMFF Donor Scar Abobotulinumtoxin-A, Control- Saline injection - Skin Cancer Excision Site, Basal Cell Carcinoma	Phase 4	Not yet recruiting	Vanderbilt University Medical Center	50	2026-09-14	2026-08-26
Multimodal Imaging of Basal Cell Carcinoma: A Usability Study Non-invasive multimodal skin imaging - Basal Cell Carcinoma of Skin		Recruiting	Bispebjerg Hospital	50	2026-09-14	2026-09-03
L19IL2/TNF in Patients With Basal Cell Carcinoma L19IL2/L19TNF - Locally Advanced Basal Cell Carcinoma	Phase 2	Recruiting	Philogen S.p.A.	92	2026-09-01	2026-07-21
AI-enhanced OCT Imaging for Pre-surgical Margin Detection of Basal Cell Carcinoma AI-OCT - Basal Cell Carcinoma of Skin		Not yet recruiting	Henry Ford Health System	30	2026-09-01	2026-05-06
A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors KUP-101A - Cutaneous Melanoma, Mucosal Melanoma	Phase 1	Recruiting	Kupando GmbH	21	2026-07-03	2026-08-12
Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies Two photon microscopy imaging - Basal Cell Carcinoma of Skin, Squamous Cell Carcinoma (Skin)	Not applicable	Recruiting	University of Rochester	92	2026-06-24	2026-08-19
Flash Radiotherapy for Skin Cancer FLASH radiotherapy, Conventional radiotherapy - Cutaneous Squamous Cell Carcinoma (CSCC), Basal Cell Carcinoma (BCC)	Phase 2	Not yet recruiting	Jules Bordet Institute	60	2026-06-23	2026-05-11
Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice Basal Cell Carcinoma of Skin, Optical Coherence Tomography (OCT)		Recruiting	Maastricht University Medical Center	297	2026-06-15	2026-10-19
Two-photon Fluorescence Microscopy of Dermatologic Biopsies Two photon microscopy imaging - Basal Cell Carcinoma of Skin, Squamous Cell Carcinoma	Not applicable	Recruiting	University of Rochester	644	2026-06-01	2026-08-19
L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) L19IL2, L19TNF, L19IL2/L19TNF - Locally Advanced Basal Cell Carcinoma	Phase 2	Recruiting	Philogen S.p.A.	180	2026-06-01	2026-07-31
AI-Based Risk Classification and Histopathological Subtype Prediction of Basal Cell Carcinoma Using Dermoscopic Images Basal Cell Carcinoma		Recruiting	Istanbul Training and Research Hospital	2500	2026-05-22	2026-06-30
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of Basal Cell Carcinoma Dermatological evaluation - Basal Cell Carcinoma		Not yet recruiting	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	20	2026-05-11	2026-05-06
A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients Topical niacinamide 5% cream, Sunscreen - Skin Cancer, Cutaneous Squamous Cell Carcinoma (CSCC)	Early Phase 1	Recruiting	Marissa Lobl	20	2026-05-01	2026-06-05
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors Methionine-Reduced Diet - Adenocarcinoma, Basal Cell Carcinoma	Early Phase 1	Recruiting	University of California, Irvine	25	2026-05-01	2026-07-31
High Intensity Focused Ultrasound vs. Cryotherapy in the Treatment of Basal Cell Carcinomas and Bowen's Disease in Adults High Intensity Focused Ultrasound, Cryotherapy - Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma	Not applicable	Not yet recruiting	Jussi Salonen	294	2026-04-01	2026-02-03
BCC-One-Stop-Study Margin Mapping with Line-field confocal optical coherence tomography - Basal Cell Carcinoma	Not applicable	Not yet recruiting	University Hospital Augsburg	290	2026-04-01	2026-03-19
Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch Syndrome Sampling of suspected skin lesions (in accordance with good care practices)., Constitution of a biobank - Basal Cell Carcinoma of Skin, Site Unspecified, Epidermoid Carcinoma	Not applicable	Recruiting	Centre Hospitalier Universitaire de Nīmes	150	2026-03-13	2026-06-22

Showing 20 of 380. Sign in to see all of them.

Narrower conditions

Skin Neoplasms (86)  ·  Carcinoma, Squamous Cell (82)  ·  Melanoma (58)  ·  Basal Cell Nevus Syndrome (35)  ·  Carcinoma, Merkel Cell (20)  ·  Keratosis, Actinic (17)  ·  Squamous Cell Carcinoma of Head and Neck (16)  ·  Carcinoma (15)  ·  Neoplasms (15)  ·  Neoplasms, Basal Cell (10)  ·  Sarcoma, Kaposi (10)  ·  Carcinoma, Transitional Cell (8)  ·  Endometrial Neoplasms (8)  ·  Uterine Cervical Neoplasms (8)

Broader conditions

Neoplasms by Histologic Type (380)  ·  Neoplasms, Glandular and Epithelial (379)  ·  Neoplasms, Basal Cell (370)  ·  Carcinoma (365)  ·  Neoplasms (365)  ·  Skin and Connective Tissue Diseases (138)  ·  Skin Diseases (133)  ·  Neoplasms by Site (130)  ·  Neoplasms, Squamous Cell (85)  ·  Neoplasms, Nerve Tissue (73)  ·  Neuroectodermal Tumors (73)  ·  Neoplasms, Germ Cell and Embryonal (72)  ·  Neuroendocrine Tumors (67)  ·  Nevi and Melanomas (60)  ·  Stomatognathic Diseases (45)

Interventions

HhAntag691 (27)  ·  Biopsy (12)  ·  Imiquimod (12)  ·  sonidegib (12)  ·  Aminolevulinic Acid (10)  ·  Nivolumab (9)  ·  Photochemotherapy (9)  ·  cemiplimab (9)  ·  1-phenyl-3,3-dimethyltriazene (8)  ·  Mohs Surgery (7)  ·  Tomography, Optical Coherence (7)  ·  methyl 5-aminolevulinate (7)  ·  Surgical Procedures, Operative (6)  ·  Ipilimumab (5)  ·  Itraconazole (5)

Sponsors

Maastricht University Medical Center (18)  ·  National Cancer Institute (NCI) (9)  ·  Novartis Pharmaceuticals (9)  ·  Bispebjerg Hospital (8)  ·  Hoffmann-La Roche (7)  ·  Memorial Sloan Kettering Cancer Center (7)  ·  Alpha Tau Medical LTD. (6)  ·  Genentech, Inc. (6)  ·  Regeneron Pharmaceuticals (6)  ·  UCSF Benioff Children's Hospital Oakland (6)  ·  Case Comprehensive Cancer Center (5)  ·  Galderma R&D (5)  ·  Mayo Clinic (5)  ·  Roswell Park Cancer Institute (5)  ·  Massachusetts General Hospital (4)

Countries

United States (166)  ·  France (33)  ·  Germany (31)  ·  United Kingdom (29)  ·  Netherlands (26)  ·  Denmark (21)  ·  Canada (20)  ·  Italy (20)  ·  Spain (19)  ·  Australia (17)  ·  Switzerland (14)  ·  Belgium (13)  ·  Israel (10)  ·  Austria (9)  ·  Greece (9)

Top investigators

Ervin Epstein, MD (6)  ·  David R. Bickers, MD (3)  ·  Edward V. Maytin, MD, PhD (3)  ·  Eidi Christensen, MD (3)  ·  Martin A. Weinstock, MD (3)  ·  Murad Alam, MD (3)  ·  Allan R. Oseroff, MD, PhD (2)  ·  Andrea Paradisi (2)  ·  Antoni Gostynski, MD, PhD (2)  ·  Daniel Eisen, M.D. (2)  ·  Evan J Lipson (2)  ·  Falk G Bechara, PD Dr. (2)

Results publications

PMID 27581207, PMID 27932240, PMID 35835136, PMID 15087400, PMID 15943729, PMID 17916094, PMID 18803580, PMID 19124815, PMID 19153339, PMID 19196482, PMID 19500127, PMID 19555364, PMID 20409337, PMID 20462662, PMID 20546215, PMID 20855696, PMID 20956641, PMID 21238825, PMID 21757257, PMID 21882176, PMID 22025453, PMID 22032650, PMID 22055282, PMID 22191035, PMID 22417254, PMID 22540308, PMID 22670903, PMID 22670904, PMID 22706476, PMID 22772403, PMID 23538779, PMID 24332516, PMID 24441673, PMID 24493717, PMID 24623282, PMID 24929884, PMID 25741400, PMID 25885553, PMID 25924874, PMID 25981810, PMID 25981813, PMID 26239203, PMID 26362616, PMID 26467274, PMID 26546616, PMID 27054919, PMID 27207349, PMID 27363577, PMID 27465252, PMID 27467121

NIH funding

2023 (4), 2025 (3), P30CA043703 (3), P30CA124435 (3), 2009 (2), P01CA084203 (2), R01CA109584 (2), R37CA258376 (2), UM1CA186691 (2), 2008 (1), 2014 (1), 2015 (1), 2016 (1), 2019 (1), KL2TR002374-07 (1)